Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT02939950
Eligibility Criteria:
Inclusion Criteria:
* Participants must be correctable through spherocylindrical refraction to 42 letters (0.1 logMAR) or better (distance, high contrast) in each eye.
* Participants must be adapted lens wearers and wear a lens in each eye; each lens must be of the same manufacturer and brand.
* Participants must be myopic and require lens correction from -0.50 diopters (D) to 6.00 D in each eye.
* Participants must have clear central corneas and be free of any anterior segment disorders.
* Participants must agree to wear their lenses on an extended wear basis (6 nights/7 days) for the duration of the study.
Exclusion Criteria:
* Participants who have worn gas permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last three months.
* Participants with an active ocular disease or who are using any ocular medication.
* Participants with any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an effect on ocular health during the course of the study.
* Participants using any systemic medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
* Participants who are not correctable to 42 letters (0.1 logMAR) in each eye with soft spherical contact lenses.
* Participants who currently wear monovision, multifocal, or toric contact lenses.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT02939950
Study Brief:
Protocol Section:
NCT02939950